-
. However, progress is constrained by the scarcity of high-quality, well-characterized in vitro T-cell immunogenicity data. In this project, we will leverage expertise and technology in peptide T-cell
-
and their mechanisms due to advances in biomedical sciences; many promising therapeutic approaches are still clinically unavailable. This is simply because there is no efficient means of delivering
Searches related to materials science
Enter an email to receive alerts for materials-science positions